follow before the Nobel Committee is ready to propose the topic and laureates of that year's Nobel Prize. The chairman of the committee presents the proposal to a larger group of scientists, in the Royal Academy of Sciences for the Prizes in chemistry and physics and at the Karolinska Institute for the Prize in medicine. After discussions, the proposal goes to a final decision, by the Royal Academy of Sciences in pleno and by the Nobel Assembly at Karolinska Institute, respectively. The decision is taken by ballot in the morning, phone calls are made around 11 am, and the press conference follows before noon. An exciting day! Candidates that are shortlisted but do not get that year's prize are often re-nominated and re-evaluated during the following years.
The criteria for the award of the Nobel Prize were defined by Alfred Nobel in his last will. The Prize in physiology or medicine can be awarded for discovery only, the one in physics for discovery or invention, and the one in chemistry for discovery or improvement. Nobel Prizes cannot be awarded for scientific leadership or lifetime achievement.
When the scientific Nobel Committees translate these rules into practice, they look for a major discovery, preferentially one that has changed the paradigm in that area of science. The next question is, who actually made the discovery? Was it the nominated scientist? Was he/she alone? Were there any other contributions to that particular discovery that should be considered? This evaluation is a long and demanding process and it usually takes several years to sort out the key issues. Once that has been done, this particular discovery and discoverer(s) can be put on the shortlist and compared with other major discoveries, in other fields of medicine (or chemistry, or physics).
Dr Jérémy Fauconnier: Which Nobel Prizes do you consider as the most important for the field of Cardiovascular Research?
Prof. Göran K. Hansson: Since the Nobel Prize in Physiology or Medicine covers such a broad field, ranging from basic biology to clinical medicine, very few awards can be made in each subfield. The cardiovascular field has been awarded several times, to scientists who have made great discoveries, and it would be wrong of me to rank them. I will just mention a few that come to my mind.
If you look at tools for therapy, the 1964 prize to Konrad Bloch and Fedor Lynen for the cholesterol synthesis pathway, together with the 1985 prize to Michael Brown and Joe Goldstein for the regulation of cholesterol metabolism, paved the way for lipid-lowering therapy. The 1982 prize to Sune Bergström, Bengt Samuelsson and John Vane for prostaglandins was crucial for thrombosis prevention, and the 1988 prize to James Black recognized the development of beta-blockers. Together, the discoveries awarded by these Nobel Prizes laid the foundation for modern cardiovascular prevention, one of the great successes in medicine.
On the diagnostic side, you have the electrocardiogram (Eindhoven 1924) and cardiac catheterization (Forssmann, Cournand, and Richards 1956) 
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and Mansfield 2003). You have some great discoveries in cardiovascular physiology, for instance Krogh's of capillary function (1920) and Furchgott's of endothelium-derived relaxation that turned out to be caused by nitric oxide (1998). In cell biology, de Duve's discovery of the lysosome (1974) is an example of a basic discovery with great relevance in cardiovascular and other areas of medicine.
Finally, molecular biology has transformed cardiovascular medicine as well as all other biomedical areas, and I think it is fair to say that the discoveries by Watson and Crick (DNA structure, Medicine Prize 1962), Jacob and Monod (gene regulation, Medicine 1965), Berg (DNA cloning, Chemistry 1980), Sanger and Gilbert (DNA sequencing, Chemistry 1980), Köhler and Milstein (monoclonal antibodies, Medicine 1984) and several others have been of enormous importance also for cardiovascular biology and medicine.
Dr Jérémy Fauconnier: The Nobel Prize is the most prestigious prize in Physiology and Medicine, and it honours a long road of research that leads to a major discovery. How could the Nobel Prize inspire the young scientists to build an academic career?
Prof. Göran K. Hansson: Every Nobel Prize tells an exciting story of how a discovery is made. Many if not all of them are made by individuals who have fought against existing, erroneous paradigms and who had to convince a sceptical world with hard evidence. Importantly, the Nobel Prize highlights the role of the creative individual, at a time when organisations, structures, and funding are often more emphasized than creativity. The Nobel Prize shows how basic science leads to great benefit for mankind. And the annals of the Nobel Prize contain fascinating narratives of the lives and work of many creative individuals. All this should be very inspiring for a young scientist. Very few of them will get the Nobel Prize but all of them can be inspired by the Nobel Prizes. Dr Hansson has made seminal contributions to cardiovascular medicine, His research deals with mechanisms of atherosclerosis, the disease that causes myocardial infarction and stroke. His discoveries concerning inflammatory mechanisms in atherosclerosis have changed the views on the cause and treatment of this disease.
Dr Hansson has published 400 scientific papers (including original papers, reviews, and chapters), supervised 24 PhD students and 18 postdoctoral fellows. 
